Myths vs facts: Longevity DNA Test and Wechseljahre

Myths vs. facts: Longevity DNA test and menopause. A longevity DNA test (e.g., MyBody-X) analyzes genes like FOXO3 (rs2764264), which are associated with longevity in population studies. However, there is no robust evidence that such single nucleotide polymorphisms (SNPs) can predict the timing or severity of menopause. Menopause is governed by a complex interplay of hormones, lifestyle, environment, and hundreds of genes. A single SNP has only a minuscule effect. The evidence for longevity tests regarding menopause is weak – they are largely marketing claims, not clinically validated predictions. Fact: A DNA test cannot replace medical advice. To understand hormone status or menopausal symptoms, rely on proven methods like hormone panels (estradiol, FSH, progesterone) and physician guidance. The value of longevity tests lies more in raising awareness of general health factors (sleep, stress, nutrition) than in specific menopause insights. Safety note: Do not base hormone therapy or prevention decisions solely on DNA results.